Evidence map›Paper›PMID 33352373›Full record

ArticleMedical image analysis2021

Feature-driven local cell graph (FLocK): New computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers.

Cheng Lu, Can Koyuncu, German Corredor, Prateek Prasanna, Patrick Leo, XiangXue Wang, Andrew Janowczyk, Kaustav Bera, James Lewis, Vamsidhar Velcheti and 1 more

Open access · greenAbstract read
In one paragraph

Article in Medical image analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Proceedings. IEEE Computer Society Conference on Computer Vision and Pattern Recognition · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. SI-MIL: Taming Deep MIL for Self-Interpretability in Gigapixel Histopathology.Proceedings. IEEE Computer Society Conference on Computer Vision and Pattern Recognition · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Cheng LuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Can KoyuncuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
German CorredorDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Prateek PrasannaDepartment of Biomedical Informatics, Stony Brook University, New York, NY, USA.
Patrick LeoDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
XiangXue WangDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Andrew JanowczykDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Precision Oncology Center, Lausanne University Hospital, Switzerland.
Kaustav BeraDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
James LewisDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Vamsidhar VelchetiPerlmutter Cancer Center, New York University, NY, USA.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH, USA. Electronic address: anant.madabhushi@case.edu.
Case Western Reserve University · USLouis Stokes Cleveland VA Medical Center · USNew York University · USStony Brook University · USVanderbilt University Medical Center · US

Funding

Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GERSON, STANTON L., KIRENGA, BRUCE JAMES · 2020 to 2024
$5.0M
Computer-Assisted Histologic Evaluation of Cardiac Allograft RejectionR01HL151277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MADABHUSHI, ANANT, MARGULIES, KENNETH BER · 2020 to 2023
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
Comprehensive quantitative ultrafast 3D liver MRIR01DK098503 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GULANI, VIKAS, SEIBERLICH, NICOLE · 2013 to 2017
$2.6M
RadxTools for assessing tumor treatment response on imagingU01CA248226 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TIWARI, PALLAVI, VISWANATH, SATISH EASWAR · 2020 to 2022
$1.4M
HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0M
Microfluidic intact cell platform: A novel tool for oral cancer detectionR21CA253108 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURKAN, UMUT A., WEINBERG, AARON · 2020 to 2020
$414k
BLRD VA I01 BX004121BLRD VA IK6 BX006185NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS R21 CA179327NCI NIH HHS R21 CA195152NCI NIH HHS R21 CA253108NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U24 CA199374NCI NIH HHS U54 CA254566NCRR NIH HHS C06 RR012463NHLBI NIH HHS R01 HL151277NIBIB NIH HHS R43 EB028736NIDDK NIH HHS R01 DK098503
6 · The paper itself

Abstract

Local spatial arrangement of nuclei in histopathology images of different cancer subtypes has been shown to have prognostic value. In order to capture localized nuclear architectural information, local cell cluster graph-based measurements have been proposed. However, conventional ways of cell graph construction only utilize nuclear spatial proximity, and do not differentiate between different cell types while constructing the graph. In this paper, we present feature-driven local cell cluster graph (FLocK), a new approach to constructing local cell graphs by simultaneously considering spatial proximity and attributes of the individual nuclei (e.g. shape, size, texture). In addition, we have designed a new set of quantitative graph-derived metrics to be extracted from FLocKs, in turn capturing the interplay between different proximally located clusters of nuclei. We have evaluated the efficacy of FLocK features extracted from H&E stained tissue images in two clinical applications: to classify short-term vs. long-term survival among patients of early stage non-small cell lung cancer (ES-NSCLC), and also to predict human papillomavirus (HPV) status of oropharyngeal squamous cell carcinoma (OP-SCCs). In the classification of long-term vs. short-term survival among patients of ES-NSCLC (training cohort, n = 434), the top 10 discriminative FLocK features related to the variation of FLocK size and intersected FLocK distance were identified, via Minimum Redundancy and Maximum Relevance (MRMR) selection, in 100 runs of 10-fold cross-validation, and in conjunction with a linear discriminant classifier yielded a mean AUC of 0.68 for predicting survival in the training cohort. This is better than other state-of-art histomorphometric and deep learning classifiers (cell cluster graphs (AUC = 0.62), global cell graph (AUC = 0.56), nuclear shape (AUC = 0.54), nuclear orientation (AUC = 0.61), AlexNet (AUC = 0.55), ResNet (AUC = 0.56)). The FLocK-based classifier yielded an AUC of 0.70 in an independent testing cohort (n = 150). The patients identified as "high-risk" had significantly poorer overall survival in the testing cohort, with a hazard ratio (95% confidence interval) of 2.24 (1.24-4.05), p = 0.01144). In the classification of HPV status of OP-SCC, the top three FLocK features pertaining to the portion of intersected FLocKs were used to construct a classifier, which yielded an AUC of 0.80 in the training cohort (n = 50), and an accuracy of 0.78 in an independent testing cohort (n = 35). The combination of FLocK measurements with cell cluster graphs, nuclear orientation, and nuclear shape improved the training AUC to 0.87, 0.91 and 0.85, respectively. Deep learning approaches yielded marginally better performance than the FLocK-based classifier in this application, with AUC = 0.78 for AlexNet, AUC = 0.81 for ResNet, and AUC = 0.76 for FLocK-based classifier in the testing cohort. However, the combination of two hand-crafted features: FLocK and nuclear orientation yielded a better performance (AUC = 0.84). FLocK provides a unique and quantitative way to analyze histology images of solid tumors and interrogate tumor morphology from a different aspect than existing histomorphometrics. The source code can be accessed at https://github.com/hacylu/FLocK.

Indexed as

AlphapapillomavirusCarcinoma, Non-Small-Cell LungLung NeoplasmsOropharyngeal NeoplasmsPapillomavirus InfectionsHumansPapillomaviridaePrognosisFeature extractionHistology image analysisLung cancerOropharyngeal cancer

Identifiers

PMID33352373
PMCPMC7855877
OpenAlexW3104211245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.